CO5580790A2 - Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs - Google Patents

Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Info

Publication number
CO5580790A2
CO5580790A2 CO04030711A CO04030711A CO5580790A2 CO 5580790 A2 CO5580790 A2 CO 5580790A2 CO 04030711 A CO04030711 A CO 04030711A CO 04030711 A CO04030711 A CO 04030711A CO 5580790 A2 CO5580790 A2 CO 5580790A2
Authority
CO
Colombia
Prior art keywords
acs
treatment
pharmaceutical composition
sulfo
phondaparinux
Prior art date
Application number
CO04030711A
Other languages
English (en)
Spanish (es)
Inventor
Anthonie Lensing
Arnold Wilhelmus
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5580790(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5580790A2 publication Critical patent/CO5580790A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CO04030711A 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs CO5580790A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204323 2001-11-13

Publications (1)

Publication Number Publication Date
CO5580790A2 true CO5580790A2 (es) 2005-11-30

Family

ID=8181220

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04030711A CO5580790A2 (es) 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Country Status (36)

Country Link
US (1) US20040248848A1 (enExample)
EP (1) EP1446131B1 (enExample)
JP (1) JP4523276B2 (enExample)
KR (1) KR20050044318A (enExample)
CN (1) CN1602197A (enExample)
AP (1) AP1820A (enExample)
AR (1) AR037291A1 (enExample)
AT (1) ATE361753T1 (enExample)
AU (1) AU2002351915B2 (enExample)
BR (1) BR0212915A (enExample)
CA (1) CA2465776A1 (enExample)
CO (1) CO5580790A2 (enExample)
CY (1) CY1106765T1 (enExample)
DE (1) DE60220084T2 (enExample)
DK (1) DK1446131T3 (enExample)
EA (1) EA007325B1 (enExample)
EC (1) ECSP045041A (enExample)
ES (1) ES2287343T3 (enExample)
GE (1) GEP20074097B (enExample)
HR (1) HRP20040303B1 (enExample)
HU (1) HU228959B1 (enExample)
IL (2) IL161114A0 (enExample)
IS (1) IS2484B (enExample)
MA (1) MA27071A1 (enExample)
ME (2) MEP1108A (enExample)
MX (1) MXPA04003045A (enExample)
NO (1) NO20041320L (enExample)
NZ (1) NZ552129A (enExample)
PE (1) PE20030740A1 (enExample)
PL (1) PL206008B1 (enExample)
PT (1) PT1446131E (enExample)
RS (1) RS50906B (enExample)
SI (1) SI1446131T1 (enExample)
UA (1) UA80399C2 (enExample)
WO (1) WO2003041722A1 (enExample)
ZA (1) ZA200402464B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075910A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fondaparinux
CN107531798B (zh) * 2015-03-20 2022-02-18 奥胡斯大学 Pcsk9的抑制剂用于脂蛋白代谢病症的治疗
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN107595769A (zh) * 2017-10-23 2018-01-19 上海博悦生物科技有限公司 一种磺达肝癸钠注射液组合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
CA2199642C (en) * 1997-03-10 2001-05-08 Roger Cariou Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
JP2006501815A (ja) * 2002-04-25 2006-01-19 モメンタ ファーマシューティカルズ インコーポレイテッド 粘膜送達のための方法および製品

Also Published As

Publication number Publication date
PE20030740A1 (es) 2003-08-28
ME00229B (me) 2011-10-10
GEP20074097B (en) 2007-05-10
NZ552129A (en) 2008-04-30
DE60220084D1 (de) 2007-06-21
HK1070561A1 (en) 2005-06-24
ES2287343T3 (es) 2007-12-16
KR20050044318A (ko) 2005-05-12
MXPA04003045A (es) 2005-06-20
RS50906B (sr) 2010-08-31
WO2003041722A1 (en) 2003-05-22
EA200400382A1 (ru) 2004-10-28
EA007325B1 (ru) 2006-08-25
CY1106765T1 (el) 2012-05-23
DE60220084T2 (de) 2008-01-10
ZA200402464B (en) 2005-06-29
HUP0401462A3 (en) 2006-04-28
IS2484B (is) 2008-12-15
CN1602197A (zh) 2005-03-30
BR0212915A (pt) 2004-10-13
ECSP045041A (es) 2004-04-28
RS26704A (sr) 2007-02-05
UA80399C2 (en) 2007-09-25
EP1446131B1 (en) 2007-05-09
MA27071A1 (fr) 2004-12-20
US20040248848A1 (en) 2004-12-09
PT1446131E (pt) 2007-08-07
JP2005509007A (ja) 2005-04-07
EP1446131A1 (en) 2004-08-18
JP4523276B2 (ja) 2010-08-11
AP1820A (en) 2008-01-11
HUP0401462A2 (en) 2006-02-28
DK1446131T3 (da) 2007-09-10
CA2465776A1 (en) 2003-05-22
NO20041320L (no) 2004-06-14
MEP1108A (en) 2011-02-10
PL206008B1 (pl) 2010-06-30
ATE361753T1 (de) 2007-06-15
IL161114A (en) 2010-11-30
AR037291A1 (es) 2004-11-03
IL161114A0 (en) 2004-08-31
PL369027A1 (en) 2005-04-18
HRP20040303B1 (hr) 2012-02-29
AP2004003014A0 (en) 2004-06-30
AU2002351915B2 (en) 2007-11-29
HU228959B1 (en) 2013-07-29
HRP20040303A2 (en) 2004-10-31
IS7199A (is) 2004-03-29
SI1446131T1 (sl) 2007-10-31

Similar Documents

Publication Publication Date Title
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
ES2081531T3 (es) Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales.
ES2091737T1 (es) Formulados farmaceuticos de fluoxetina.
EA199801086A1 (ru) Неводные медицинские средства для очистки толстой кишки
AR033688A1 (es) Composicion parenteral reconstituible
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
BR0112080A (pt) Vetores particulados para aperfeiçoamento da absorção oral de principios ativos
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
DK0538011T3 (da) Saltsammensætninger omfattende lipofilt oligosaccharidantibiotikum.
NO994431L (no) Ny formulering
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
CY1106765T1 (el) Χρηση ειδικης δοσης του νατριουχου φονταπαρινιδιου για τη θεραπεια των acs
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda

Legal Events

Date Code Title Description
FC Application refused